open access
메뉴
open access
메뉴
ISSN : 0376-4672
Peri-implant diseases are prevalent with a weighted mean prevalence rate of 43% across Europe and 22% across South and North America. Although the main etiologic agent is bacterial biofilm, various factors influ ence the initiation and progression of the disease. Unfortunately, the treatment of peri-implant diseases is at best favorable in the short term with a high rate of persistent inflammation and recurrence. Therefore, it is sensible to consider and control all potential factors that may predispose an implant to peri-implant tissue inflammation in an attempt to avoid the disease. If periodic maintenance treatment is not performed, there is a high probability of recurrence of the disease and can lead to the loss of the implant.
1. Moraschini V, Poubel LA, Ferreira VF, Barboza Edos S. Evaluation of survival and success rated of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg. 2015;44(3):377-388.
2. Jia-Hui Fu, Hom-Lay Wang. Breaking the wave of peri-implantitis. Periodontol 2000. 2020;84(1):145-160.
3. Caton JG, Amitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions-Introduction and key changes from the 1999 classification. J Clin Periodontol. 2018;45(suppl 20):S1-S8.
4. Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Clin Periodontol. 2018;45(Suppl20):S237-S245.
5. Schwarz F, Derks J, Monje A, et al. Peri-implantitis. J Clin Periodontol. 2018;45:246-266.
6. Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: Consensus report of Workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-implant diseases and conditions. J Clin Periodontol. 2018;45:286-291.
7. Derks J, Schaller D, Hakansson J, et al. Peri-implantitis onset and pattern of progression. J Clin Periodontol. 2016;43(4):383-388.
8. Derk J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015;42(suppl16):S158-S171.
9. Ahn DH, Kim HJ, Joo JY, Lee JY. Prevalence and risk factors of periimplant mucositis and peri-implantitis after at least 7 years of loading. J Periodontol Implant Sci. 2019;49(6):397-405.
10. Heitz-Mayfield LJ, Aaboe M, Araujo M, et al. Group 4 ITI consensus report: risks and biologic complications associated with implant dentisty. Clin Oral Implant Res. 2018;29(Suppl16):351-358.
11. Renvert S, Polyzois I. Treatment of pathologic peri-implant pockets. Periodontol 2000.2018;76(1):180-190.
12. Suarez-Lopez Del Amo F, Yu SH, Wang HL. Non-surgical therapy for peri-implant diseases: a systematic review. J Oral Maxillofac Res. 2016;7(3):e13.
13. Schwarz F, Jepsen S, Obreja K, Galarraga-Vinueza ME, Ramanauskaite A. Surgical therapy of peri-implantitis. Periodontol 2000, 2022;88(1):145-181.
14. Heitz-Mayfield LJA, Salvi GE, Mombelli A, et al. Supportive periimplant therapy following anti-infective surgical peri-implantitis treatment: 5-year survival and success. Clin Oral Implants Res. 2018;29(1):1-6.
15. Renvert S, Polyzois I. Treatment of pathologic peri-implant pockets. Periodontol 2000. 2018;76(1):180-190/.
16. Jepsen S, Schwarz F, Cordaro L, et al. Regeneration of alveolar ridge defects. Consensus report of Group 4 of the 15th European Workshop on Periodontology on Bone Regeneration. J Clin Periodontol. 2019;46:277-286.
17. Schwarz F, Sahm N, Schwarz K, et al. Impact of defect configuration on the clinical outcome following surgical regenerative therapy of peri-implantitis. J Clin Periodontol. 2010;37(5): 449-455.
18. Ramanauskatie A, Becker K, Juodzbalys G, et al. Clinical outcomes followings surgical treatment of peri-implantitis at grafted and nongrafted implant sites: a retrospective analysis. Int J Implant Dent. 2018;4(1):27.
19. Roccuzzo M, Layton DM, Roccuzzo A, et al. Clinical outcomes of peri-implantitis treatment and supportive care: a systematic review. Clin Oral Implants Res. 2018;29(16):331-350.